The Journal of

1-Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.
2-Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299(23):2751-9.
3-De Groot M, Doyle T, Averyt J, Risaliti C, Shubroo J. Depressive symptoms and type 2 diabetes mellitus in rural appalachia: an 18-month follow-up study. Int J Psychiatry Med. 2015;48(4):263-77
4-Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes a meta-analysis. Diabetes care. 2001;24(6):1069-78.
5-Zoe R. Anxiety and depression in patients with type 2 diabetes mellitus, depending on sex and body mass index. Health Science Journal. 2009: 3 (1): 32-40.
6-Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. The Lancet. 1997;349(9064):1498-504.
7-Sadeghirad B, Ali-Akbar H, Amin-Esmaeili M, Ananloo ES, Ghaeli P, Rahimi-Movaghar A, et al. Epidemiology of major depressive disorder in iran: a systematic review and meta-analysis. International journal of preventive medicine. 2010;1(2):81-91.
8-Richards D. Prevalence and clinical course of depression: a review. Clinical psychology review. 2011;31(7):1117-25.
9-Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes care. 2004;27(9):2154-60.
10-Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. General hospital psychiatry. 2003;25(4):246-52.
11-Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes a prospective cohort study. Diabetes care. 2010;33(2):264-9.
12-Katon WJ, Lin EH, Williams LH, Ciechanowski P, Heckbert SR, Ludman E, et al. Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study. Journal of general internal medicine. 2010;25(5):423-9.
13-Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes care. 2003;26(10):2822-8.
14-Kawahito S, Kitahata H, Oshita S. Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol. 2009;15(33):4137-42.
15-Karunakaran U, Park K-G. A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense. Diabetes & metabolism journal. 2013;37(2):106-12.
16-Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation research. 2010;107(9):1058-70.
17-Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;622-559:(5)23;002.
18-McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert opinion on drug safety. 2006;5(1):157-68.
19-Erenmemisoglu A, Ozdogan U, Saraymen R, Tutus A. Effect of Some Antidepressants on Glycaemia and Insulin Levels of Normoglycaemic and Alloxan‐induced Hyperglycaemic Mice. Journal of Pharmacy and Pharmacology. 1999;51(6):741-3.
20-Anjaneyulu M, Chopra K, Kaur I. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. Journal of medicinal food. 2003;6(4):391-5.
21-Cemek M, Kaga S, Simsek N, Buyukokuroglu ME, Konuk M. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats. J Nat Med. 2008;62(3):284-93.
22-Srivastava JK, Shankar E, Gupta S. Chamomile: A herbal medicine of the past with bright future. Molecular medicine reports. 2010;3(6):895.
23-Maschi O, Cero ED, Galli GV, Caruso D, Bosisio E, Dell’Agli M. Inhibition of Human cAMP-Phosphodiesterase as a Mechanism of the Spasmolytic Effect of Matricaria recutita L. Journal of agricultural and food chemistry. 2008;56(13):5015-20.
24-Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochemical pharmacology. 2000;59(11):1387-94.
25-Petronilho S, Maraschin M, Coimbra MA, Rocha SM. In vitro and in vivo studies of natural products: A challenge for their valuation. The case study of chamomile (Matricaria recutita L.). Industrial Crops and Products. 2012;40:1-12.
26-Zemestani M, Rafraf M, Asghari-Jafarabadi M. Chamomile tea improves glycemic indices and antioxidants status in patients with type 2 diabetes mellitus. Nutrition. 2015;14(15):00328-7.
27-Amsterdam JD, Shults J, Soeller I, Mao JJ, Rockwell K, Newberg AB. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study. Altern Ther Health Med. 2012;18(5):44-9.
28-Chang SM, Chen CH. Effects of an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: a randomized controlled trial. J Adv Nurs. 2016;72(2):306-15.
29-Anesini C, Ferraro GE, Filip R. Total polyphenol content and antioxidant capacity of commercially available tea (Camellia sinensis) in Argentina. J Agric Food Chem. 2008;56(19): 225-9.
30-Dabson K, Mohammad KP. Psychometric characteristics of Beck depression inventory–II in patients with major depressive disorder. 2007.
31-Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radical Biology and Medicine. 1996;20(2):251-6.
32-Janaszewska A, Bartosz G. Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scandinavian journal of clinical and laboratory investigation. 2002;62(3):231-6.
33-Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 2009;29(4):378-82.
34-Pinto SA, Bohland E, Coelho Cde P, Morgulis MS, Bonamin LV. An animal model for the study of Chamomilla in stress and depression: pilot study. Homeopathy. 2008;97(3):141-4
35-Yi LT, Li JM, Li YC, Pan Y, Xu Q, Kong LD. Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life Sci.2008;8(51):741.
36-Kanazawa I. Short review on monoamine oxidase and its inhibitors. European neurology. 1994;34(Suppl. 3):36-9
37-Nakazawa T, Yasuda T, Ueda J, Ohsawa K. Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol Pharm Bull. 2003;26(4):474-80.
38-Singh A, Naidu PS, Kulkarni SK. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition. Pharmacology. 2003;68(2):81-8.
39-Pal SN, Dandiya P. Glutathione as a cerebral substrate in depressive behavior. Pharmacology Biochemistry and Behavior. 1994;48(4):845-51.
40-Jabri MA, Sani M, Rtibi K, Marzouki L, El-Benna J, Sakly M, et al. Chamomile decoction extract inhibits human neutrophils ROS production and attenuates alcohol-induced haematological parameters changes and erythrocytes oxidative stress in rat. Lipids Health Dis. 2016;15(1): 233-4.
41-Sebai H, Jabri MA, Souli A, Rtibi K, Selmi S, Tebourbi O, et al. Antidiarrheal and antioxidant activities of chamomile (Matricaria recutita L.) decoction extract in rats. J Ethnopharmacol. 2014;152(2):327-32.
42-Ramadan KS, Emam MA. Biochemical evaluation of antihyperglycemic and antioxidative effects of matricaria chamomilla leave extract studied in streptozotocin-induced diabetic rats. Int J Res Manag Technol. 2012;2:298-302.
43-Emam MA. Comparative evaluation of antidiabetic activity of Rosmarinus officinalis L. and Chamomile recutita in streptozotocin induced diabetic rats. Agric Biol J North Am. 2012;3(3):247.
44-Bhaskaran N, Srivastava JK, Shukla S, Gupta S. Chamomile confers protection against hydrogen peroxide-induced toxicity through activation of Nrf2-mediated defense response. Phytother Res. 2013;27(1):118-25.